Dr. Fava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-724-0838Fax+1 617-726-2688
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1985 - 1988
- University of Padua College of MedicineClass of 1982
Certifications & Licensure
- WA State Medical License 1984 - 2026
- MA State Medical License 1988 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression Start of enrollment: 2005 Apr 01
- Bupropion as an Adjunct to the Nicotine Patch Plus CBT Start of enrollment: 1999 Apr 01
- Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking Start of enrollment: 2006 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 257 citationsWeight gain and antidepressants.Maurizio Fava
The Journal of Clinical Psychiatry. 2000-09-30 - 167 citationsFluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.Maurizio Fava, Rajinder Judge, Sharon L. Hoog, Mary E. Nilsson, Stephanie C. Koke
The Journal of Clinical Psychiatry. 2000-10-31 - 123 citationsEvaluation of Opioid Modulation in Major Depressive DisorderElliot Ehrich, Ryan Turncliff, Yangchun Du, Richard Leigh-Pemberton, E. Fernandez
Neuropsychopharmacology. 2015-05-01
Journal Articles
- Research Paper Tachyphylaxis in Major Depressive Disorder: A Review of the Current State of ResearchGustavo Kinrys, Andrew A Nierenberg, George I Papakostas, David Mischoulon, Maurizio Fava, Marlene P Freeman, ScienceDirect
- Research Paper Understanding the Effects of Emotional Reactivity on Depression and Suicidal Thoughts and Behaviors: Moderating Effects of Childhood Adversity and Resil...Benjamin G Shapero, Daphne J Holt, Amy Farabaugh, Joey C Cheung, Maurizio Fava, ScienceDirect
- Can Electronic Health Records Revive Central Nervous System Clinical Trials?Maurizio Fava, Roy H Perlis, Nature
- Join now to see all
Authored Content
- S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
- S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
- S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
- S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
- Characterizing Anxiety Subtypes and the Relationship to Behavioral Phenotyping in Major Depression: Results from the EMBARC StudyApril 2018
- Characterizing Anxiety Subtypes and the Relationship to Behavioral Phenotyping in Major Depression: Results from the EMBARC StudyApril 2018
- Join now to see all
Press Mentions
- ABVC BioPharma Provides 2023 Pipeline UpdateFebruary 28th, 2023
- Relmada Therapeutics Announces Top-Line Results from Phase 3 RELIANCE III Trial for REL-1017 as a Monotherapy for the Treatment of Major Depressive DisorderOctober 13th, 2022
- Relmada Shares Collapse After Fast-Acting Depression Drug Fails First TestOctober 13th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: